Contents  by unknown
STATE-OF-THE-ART
PAPER
587The Changing Face of Heart Transplantation
Sharon A. Hunt, Franc¸ois Haddad
CLINICAL RESEARCH
Invasive Cardiology
599Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy
in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Mauro Maioli, Anna Toso, Mario Leoncini, Michela Gallopin, Delio Tedeschi, Carlo Micheletti,
Francesco Bellandi
Obesity and
Heart Disease
605Measures of Obesity and Cardiovascular Risk Among Men and Women
Rebecca P. Gelber, J. Michael Gaziano, E. John Orav, JoAnn E. Manson, Julie E. Buring, Tobias Kurth
EDITORIAL COMMENT
616Which Measures of Obesity Best Predict Cardiovascular Risk?
Sheldon E. Litwin
620The Relationship Between Obesity and Atherosclerotic Progression and
Prognosis Among Patients With Coronary Artery Bypass Grafts:
The Effect of Aggressive Statin Therapy
Christina C. Wee, Saket Girotra, Amy R. Weinstein, Murray A. Mittleman, Kenneth J. Mukamal
Lipid Reduction
Therapy
626Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density
Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets
in High-Risk Patients: The MERCURY II (Measuring Effective Reductions in
Cholesterol Using Rosuvastatin therapY II) Trial
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain
EDITORIAL COMMENT
633Re-Evaluating Therapeutic Target Goals for Statin-Treated Patients:
Time for Revolutionary Changes?
Yaakov Henkin
CONTENTS
AUGUST 19, 2008
VOLUME 52, NO. 8
Journal of the American College of Cardiology (ISSN: 0735-1097) is published weekly except for the first 2 weeks in Jan and the last 2 weeks inDec when they
are combined by Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Business and Editorial Offices: 1600 John F. Kennedy Boulevard,
Philadelphia, PA 19103-2899. Accounting and Circulation Offices: 6277 Sea Harbor Drive, Orlando, FL 32887-4800. Periodicals postage paid at New
York, NY and additional mailing offices. POSTMASTER: Send address changes to Journal of the American College of Cardiology, Elsevier Periodicals
Department, 6277 Sea Harbor Drive, Orlando, FL 32887-4800. CUSTOMER SERVICE (orders, claim, online, change of address): Elsevier Periodicals
Customer Service, 6277 SeaHarborDrive,Orlando, FL 32887-4800. Tel: (800) 654-2452 (U.S. andCanada); (407) 563-6020 (outsideU.S. andCanada).
Fax: (800) 225-4030 (U.S. andCanada); (407) 363-9661 (outside U.S. andCanada). E-mail: JournalsCustomerService-usa@elsevier.com. Address changes
must be submitted four weeks in advance. YEARLY SUBSCRIPTION RATES (for 2008): For customers in the USA and Canada: institutional rate: US
$520.00; for customers outside theUSAandCanada: institutional rate:US$707.00. For customers in theUSAonly: personal rate:US$275.00, resident rate:
US$99.00; for customers outsideUSA:personal rate:US$413.00, resident rate:US$207.00.Prices includepostage and are subject to changewithoutnotice.
Cardiac Imaging 636Comprehensive Assessment of Coronary Artery Stenoses: Computed Tomography
Coronary Angiography Versus Conventional Coronary Angiography and Correlation With
Fractional Flow Reserve in Patients With Stable Angina
W. Bob Meijboom, Carlos A. G. Van Mieghem, Niels van Pelt, Annick Weustink, Francesca Pugliese,
Nico R. Mollet, Eric Boersma, Eveline Regar, Robert J. van Geuns, Peter J. de Jaegere, Patrick W. Serruys,
Gabriel P. Krestin, Pim J. de Feyter
Heart Failure 644Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart
Failure Patients Treated With Carvedilol or Metoprolol
Amy J. Sehnert, Susan E. Daniels, Michael Elashoff, James A. Wingrove, Christopher R. Burrow,
Benjamin Horne, Joseph B. Muhlestein, Mark Donahue, Stephen B. Liggett, Jeffrey L. Anderson,
William E. Kraus
See additional content on www.onlinejacc.org
EDITORIAL COMMENT
652Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?
Douglas L. Mann, Dennis M. McNamara
PRECLINICAL
RESEARCH
655Metallothionein Suppresses Angiotensin II–Induced Nicotinamide Adenine Dinucleotide
Phosphate Oxidase Activation, Nitrosative Stress, Apoptosis, and Pathological
Remodeling in the Diabetic Heart
Guihua Zhou, Xiaokun Li, David W. Hein, Xilin Xiang, James P. Marshall, Sumanth D. Prabhu, Lu Cai
See additional content on www.onlinejacc.org
EDITORIAL COMMENT
667Metallothionein Reverses the Harmful Effects of Angiotensin II on the Diabetic Heart
Walmor C. De Mello
EDITOR’S PAGE 670Tipping Points and Cardiology
Anthony N. DeMaria
JACC
AUGUST 19, 2008 (contents continued)
CORRESPONDENCE
Research
Correspondence
672Enrollment of Women in National Heart, Lung, and Blood Institute-Funded
Cardiovascular Randomized Controlled Trials Fails to Meet Current
Federal Mandates for Inclusion
Esther S. H. Kim, Thomas P. Carrigan, Venu Menon
See additional content on www.onlinejacc.org
Letters to the Editor 674Repolarization Measurement in Brugada Syndrome
Arthur M. Yue
Reply
Satoshi Nagase, Kengo Fukushima Kusano, Hiroshi Morita, Tohru Ohe
ACC/AHA
PRACTICE GUIDELINE:
FOCUSED UPDATE
676ACC/AHA 2008 Guideline Update on Valvular Heart Disease:
Focused Update on Infective Endocarditis
Rick A. Nishimura, Chair
AHA/ACC
EXPERT CONSENSUS
DOCUMENT
686Sleep Apnea and Cardiovascular Disease
Virend K. Somers, Chair, David P. White, Co-Chair, Raouf Amin, Co-Chair
JACC
AUGUST 19, 2008 (contents continued)
ON THE COVER A 25-year-old male was referred for evaluation of fatigue and decreased exercise
tolerance. On physical examination, he was noted to have a grade III/VI diastolic murmur
heard best at the left upper sternal border, consistent with at least a moderate degree of
aortic regurgitation (AR). Transthoracic echocardiography (TTE) identified a quadricuspid
aortic valve (QAV) with 4 equal size cusps and a moderate degree of aortic regurgitation
(A and B, Video 1). The patient underwent cardiac magnetic resonance (CMR) imaging
confirming the QAV with a moderate degree of AR (regurgitant fraction 30%) and a dilated
ascending aorta (C, Video 2). 64-slice multidetector computed tomography (MDCT)
revealed normal coronary anatomy, a QAV, and a moderate degree of AR with a regurgitant
orifice area of 0.18 cm2 (D, Video 3). QAV is a rare congenital anomaly of the aortic valve,
with an incidence ranging between 0.0125% and 0.033%. QAVs have been reported in
association with other cardiac abnormalities, such as anomalies of coronary artery origin,
pulmonary valve stenosis, atrial septal defect, ventricular septal defect, fibromuscular
subaortic stenosis, and supravalvular stenosis with left coronary atresia. Aortic valvular
insufficiency usually develops due to fibrous thickening with incomplete coaptation of the
cusps. Although a rare congenital anomaly, QAVs may be associated with significant AR
as well as other cardiac anomalies, requiring thorough evaluation by the use of
complementary cardiac imaging, including echocardiography, MDCT, and CMR, prior to
surgical intervention. For accompanying videos, please see the online version of the
issue.
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